Efficacy and Safety of Sacubitril/Valsartan in Hemodialysis Patients with Hypertensio

Not Applicable

• Conditions: End-stage renal failure

• Registration Number: JPRN-UMIN000049348
• Lead Sponsor: Kansai Medical University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-01
• Last Update Posted: 17 October 2023
• Study Completion: 2024-03-31

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 27

Inclusion Criteria

Not provided

Exclusion Criteria

1. Non-sinus rhythm 2. Life expectancy of less than one year 3. Apparent infection 4. Myocardial infarction and/or stroke within 30 days 5. Current pregnancy 6. Malignancy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Comparison of blood pressure during hemodialysis after 3 months.

Secondary Outcome Measures

Name	Time	Method
1. Change in home blood pressure 2. Change in liver function and electrolytes 3. Change in NT-proBNP